Security key
68403P203
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)
CUSIP: 68403P203
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock par value $0.012 per share
- Total 13F shares
- 9,033,365
- Total 13F value
- $78,273,671
- Share change
- +410,814
- Put/Call ratio
- 44%
- SEC-reported price per share
- $8.65
- Number of holders
- 99
- Value change
- -$349,248
- Number of buys
- 42
- Number of sells
- 51
- Shares outstanding
- 41,050,760
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
99
Top holders
10
ORMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2022
Previous quarter: Q4 2021
ORAMED PHARMACEUTICALS INC. SEC filings
ORAMED PHARMACEUTICALS INC. company facts
ORAMED PHARMACEUTICALS INC. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 68403P203
Recent filing periods:
Ownership snapshot
Top reported holders of ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 3.8%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 3.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
3.8%
MILLENNIUM MANAGEMENT LLC
1.9%
CITADEL ADVISORS LLC
1.3%
STATE STREET CORP
1.2%
TWO SIGMA INVESTMENTS, LP
0.98%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
3.8%
|
$22,257,000
1,558,607 shares
|
— | 31 Dec 2021 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.9%
|
$10,875,000
761,570 shares
|
— | 31 Dec 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.3%
|
$7,629,000
534,225 shares
|
— | 31 Dec 2021 |
| STATE STREET CORP |
13F
Company
|
1.2%
|
$7,315,000
512,246 shares
|
— | 31 Dec 2021 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
0.98%
|
$5,742,000
402,097 shares
|
— | 31 Dec 2021 |
| MORGAN STANLEY |
13F
Company
|
0.94%
|
$5,520,000
386,603 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
99
Shares
9,033,365
Rows available
99
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
114
Q1 2022 holders
99
Holder diff
-15
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend